BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33358669)

  • 21. Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
    Ikemura N; Spertus JA; Kimura T; Mahaffey K; Piccini JP; Inohara T; Ueda I; Tanimoto K; Suzuki M; Nakamura I; Akaishi M; Mitamura H; Fukuda K; Takatsuki S; Kohsaka S
    BMJ Open; 2019 Dec; 9(12):e032746. PubMed ID: 31857312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
    Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
    J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and health-status outcomes in patients with atrial fibrillation detected via health screening.
    Yamashita T; Kimura T; Ikemura N; Niimi N; Tsuzuki I; Seki Y; Ibe S; Hashimoto K; Miyama H; Fujisawa T; Katsumata Y; Tanimoto K; Nagami K; Suzuki M; Kohsaka S; Fukuda K; Takatsuki S
    Clin Cardiol; 2023 Jan; 46(1):32-40. PubMed ID: 36300885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Atrial Fibrillation-Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?
    Björkenheim A; Brandes A; Magnuson A; Chemnitz A; Svedberg L; Edvardsson N; Poçi D
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1168-1176. PubMed ID: 29759501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation of atrial fibrillation guided by a 3D electroanatomical mapping system: a 2-year follow-up study from the Italian Registry On NavX Atrial Fibrillation ablation procedures (IRON-AF).
    Forleo GB; De Martino G; Mantica M; Menardi E; Trevisi N; Faustino M; Muto C; Perna F; Santamaria M; Pandozi C; Pappalardo A; Mancusi C; Romano E; Della Bella P; Tondo C
    J Interv Card Electrophysiol; 2013 Jun; 37(1):87-95. PubMed ID: 23397247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of improvement in arrhythmia-specific symptoms and health-related quality of life after catheter ablation of atrial fibrillation.
    Barmano N; Charitakis E; Karlsson JE; Nystrom FH; Walfridsson H; Walfridsson U
    Clin Cardiol; 2019 Feb; 42(2):247-255. PubMed ID: 30548275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
    Mol D; Boersma AM; Berger WR; Khan M; de Ruiter GS; Kimman GP; de Groot JR; de Jong JSSG
    PLoS One; 2022; 17(1):e0261841. PubMed ID: 35061716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
    Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
    J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful catheter ablation improves exercise tolerance in persistent atrial fibrillation patients, especially those with reduced ventricular contraction, preserved atrial function, or a high CHADS
    Katayama H; Shibata A; Doi A; Ishikawa H; Tamura S; Yamaguchi Y; Matsuo M; Yoshiyama T; Tatsumi H; Iwata S; Ehara S; Izumiya Y; Yoshiyama M
    J Cardiol; 2020 May; 75(5):529-536. PubMed ID: 31708409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physician Estimates and Patient-Reported Health Status in Atrial Fibrillation.
    Ikemura N; Kohsaka S; Kimura T; Jones PG; Katsumata Y; Tanimoto K; Ueda I; Takatsuki S; Ieda M; Chan PS; Spertus JA
    JAMA Netw Open; 2024 Feb; 7(2):e2356693. PubMed ID: 38393730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
    Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
    Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
    Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Radiofrequency Catheter Ablation Between Asymptomatic and Symptomatic Persistent Atrial Fibrillation: A Propensity Score Matched Analysis.
    Wu L; Lu Y; Zheng L; Qiao YU; Chen G; Ding L; Hou B; Sun W; Liew R; Zhang S; Yao Y
    J Cardiovasc Electrophysiol; 2016 May; 27(5):531-5. PubMed ID: 26773415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry.
    Stabile G; Trines SA; Arbelo E; Dagres N; Brugada J; Kautzner J; Pokushalov E; Maggioni AP; Laroche C; Anselmino M; Beinart R; Traykov V; Blomström Lundqvist C;
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):313-320. PubMed ID: 30632196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
    Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
    Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
    Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Female Sex on Clinical Presentation and Ablation Outcomes in the CIRCA-DOSE Study.
    Yao RJR; Macle L; Deyell MW; Tang L; Hawkins NM; Sedlak T; Nault I; Verma A; Khairy P; Andrade JG;
    JACC Clin Electrophysiol; 2020 Aug; 6(8):945-954. PubMed ID: 32819529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.